Amendment103rd Congress
1725
- Amendment Number
- 1725
- Purpose
- To require a screening program to test certain substances to determine whether the substances may have effects in humans similar to the effects produced by naturally occurring estrogens, or other endocrine effects.
- Congress
- 103
- Type
- SAMDT
- Latest Action Date
- May 18, 1994
- Latest Action Text
- Amendment SP 1725 agreed to in Senate by Voice Vote.
- Proposed Date
- May 18, 1994
- Submitted Date
- May 18, 1994
- Chamber
- Senate
- Update Date
- Aug 14, 2021